Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Beam Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get BEAM alerts

About Michael Yee

Michael Yee has spoken on 1 investor event across 1 company, most recently for Beam Therapeutics Inc. on November 17, 2026. Beam Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Beam Therapeutics Inc. includes John Evans (CEO, Chief Accounting Officer and Board Member), Sravan Emany (CFO), Sravan K. Emany (CFO) and 7 others.

Michael Yee on recent calls

“I hope everyone had a great lunch here at the UBS Global Biopharma Conference. Michael Yee, Global Head of Biotech Research here at UBS, and really pleased to have up on stage with us Beam Therapeutics, Chief Executive Officer John Evans.”
Other, UBS Global Biopharma Conference ·

Affiliation history

Company network

Leadership on record at Beam Therapeutics Inc.

Recent activity